Skip to main content

BNP PARIBAS ARBITRAGE, SA

Position in NVCR — NovoCure Ltd

CIK 1166588 NEW YORK, NY

Position in NVCR

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$7,720,393
+$4,564,543 QoQ
Shares Held
708,293
+190.2% QoQ
Ownership
0.612%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in NVCR Over Time

Shares Held

Position Value (USD)

Derivatives in NVCR

reported options exposure · as of Dec 31, 2023
CallValue
$0
CallShares
0
PutValue
$12,690
PutShares
850

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

BNP PARIBAS ARBITRAGE, SA holds $1,711,272,501 across 97 Medical Devices names. NVCR ranks #20 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVCR

Export CSV
30 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $7,720,393 708,293
2025-12-31 $3,155,850 244,072
2025-09-30 $883,211 68,360
2025-06-30 $521,201 29,281
2025-03-31 $778,644 43,695
2024-12-31 $850,939 28,555
2024-09-30 $2,749,723 175,926
2024-06-30 $3,988,275 232,824
2024-03-31 $581,107 37,179
2023-12-31 $2,245,681 150,414
2023-12-31 $12,690 850
2023-09-30 $2,786,537 172,541
2023-06-30 $5,502,277 132,585
2023-03-31 $1,945,529 32,350
2022-12-31 $2,015,584 27,479
2022-09-30 $2,764,988 36,391
2022-06-30 $7,225,984 103,971
2022-03-31 $5,351,944 64,598
2021-12-31 $9,009 120
2021-12-31 $6,244,253 83,168
2021-09-30 $3,088,263 26,584
2021-09-30 $13,940 120
2021-06-30 $26,618 120
2021-06-30 $6,777,710 30,555
2021-03-31 $15,861 120
2021-03-31 $2,129,287 16,109
2020-12-31 $4,127,004 23,850
2020-09-30 $638,808 5,739
2020-06-30 $3,819,631 64,412
2020-03-31 $2,325,384 34,532